Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Cemiplimab and Fianlimab With Neoadjuvant Chemotherapy in Early-Stage High-Risk ERBB2-Negative Breast Cancer: The I-SPY2 Randomized Clinical Trial.
Journal: JAMA oncology
Published: July 30, 2026
Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 09, 2026
Adrenal Suppression From Mucosal Absorption of Dexamethasone Mouthwash.
Journal: Cureus
Published: March 31, 2026
LHPP expression in triple-negative breast cancer promotes tumor growth and metastasis by modulating the tumor microenvironment.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 04, 2025
Aging alters tumor cell - T cell crosstalk to promote breast cancer progression.
Journal: bioRxiv : the preprint server for biology
Published: December 03, 2025
Zanidatamab, a Dual HER2-Targeted Bispecific Antibody, in Patients with Unresectable Locally Advanced or Metastatic HER2-Positive Salivary Gland Cancer: A Combined Analysis of Early-Phase Studies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 20, 2025
NCCN Guidelines® Insights: Breast Cancer, Version 5.2025.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: November 10, 2025
Ultrasensitive ctDNA monitoring reveals early predictors of immunotherapy response in advanced cancer.
Journal: NPJ precision oncology
Published: October 07, 2025
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.
Journal: Nature medicine
Published: August 07, 2024
Last Updated: 09/26/2026